Millennium Management LLC Increases Stake in ALX Oncology Holdings Inc. to 1.5%

On April 28, 2026, Millennium Management LLC and associated reporting persons, including Israel A. Englander, filed a Schedule 13G/A regarding their holdings in ALX Oncology Holdings Inc. (ALXO). The filing indicates that Millennium Management LLC now beneficially owns 1,988,559 shares of Common Stock, representing approximately 1.5% of the class. This reflects an increase from a previously reported 0.0% ownership position. The shares are held by various entities under the voting control and investment discretion of Millennium Management LLC, Millennium Group Management LLC, and Mr. Englander. Specifically, Integrated Core Strategies (US) LLC, one of the reporting entities, directly holds 730,528 shares (0.5%). The filing was made pursuant to Rule 13d-1(c), certifying that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The event triggering this amendment occurred on March 31, 2026.